http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2541150-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_511f6422bd60c264b64e83866b0736ec |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48 |
| filingDate | 2013-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ca3ca8aec5b0f9c922de13eea279c80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0225cc8e0133e813fed9739a443c986c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7874d9fe76560fdacf7949c8cdb69317 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc329160a5ec2683094bb18acd61f3e7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69e4efd3f72dc543b748446078747714 |
| publicationDate | 2015-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2541150-C1 |
| titleOfInvention | Differential diagnostic technique for meningitis in children |
| abstract | FIELD: medicine. n SUBSTANCE: effective therapy and prevention of neurological impairment require the timely and earliest possible diagnosing of a disease and the validation of its nature. The early differential diagnosing of the viral or bacterial origin of the disease promotes prescribing the adequate initial etiological treatment, reduces the spreading process, the agent eradication, the cerebrospinal fluid sanitation, and improves the clinical outcome of the disease. What is presented is a novel differential diagnostic technique for viral and bacterial meningitis providing the accuracy and expressivity by determining the total haptoglobin concentration in the cerebrospinal fluid. The spinal fluid sampled by a diagnostic lumbar puncture in the acute period of the disease, is additionally examined for the total haptoglobin concentration for 1 hour by qualitative immunoturbidimetric technique; if the concentration is 0.7 mg/dl or less, viral meningitis is diagnosed, while the concentration of more than 0.7 mg/dl shows bacterial meningitis. n EFFECT: rapid and accurate determination of the viral or bacterial origin of meningitis at the early stage of the disease and prescription of the adequate initial etiological treatment. n 2 tbl, 4 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2695359-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2759025-C1 |
| priorityDate | 2013-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 70.